Michael P. Arend;Al Y. Lin;Qingjian Wang;Thomas B. Neff;Volkmar Guenzler-Pukall;Stephen J. Klaus;Alex Melekhov;Lee A. Flippin
发明人:
Stephen J. Klaus,Al Y. Lin,Thomas B. Neff,Qingjian Wang,Volkmar Guenzler-Pukall,Michael P. Arend,Lee A. Flippin,Alex Melekhov
申请号：
US13614917
公开号：
US20130203805A1
申请日:
2012.09.13
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to methods for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo. Methods for treating, pretreating or preconditioning, or preventing erythropoietin-associated conditions are also included. Compounds for use in these methods are provided, as are methods of identifying such compounds.
